Antagonism of the bradykinin B2-receptor, which is supposed to largely convey the increase in vascular permeability leading to acute angioedema in HAE, via the B2-receptor antagonist Icatibant is an entirely different approach. The gene discussed is BDKRB2; the disease is angioedema.